Has Wei Zhao, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,489 in general payments to Wei Zhao, MD across 372 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wei Zhao, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wei Zhao, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wei Zhao, MD

Nephrology · Norfolk, VANPI 1205834405

Payments from drug & device makers

$8,489in general payments, 2019–2025

Across 372 payments — averaging $22.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$921
AstraZeneca$804
Travere Therapeutics, Inc.$797
Otsuka America Pharmaceutical, Inc.$750
GSK$537
Ardelyx, Inc.$458
plus $4K from 35 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	37	$921
AstraZeneca(2 entities)	40	$804
Travere Therapeutics, Inc.	41	$797
Otsuka America Pharmaceutical, Inc.	29	$750
GSK	29	$537
Ardelyx, Inc.	21	$458
Kyowa Kirin, Inc.	6	$424
Novartis	12	$341
Bayer	11	$320
Axsome Therapeutics, Inc.	12	$316
Mallinckrodt Hospital Products Inc.	10	$281
Akebia Therapeutics Inc	12	$279
Lilly USA, LLC	16	$256
Vifor Pharma, Inc.	10	$226
Aurinia Pharma U.S., Inc.	9	$193
Dexcom, Inc.	10	$174
Calliditas Therapeutics US Inc.	6	$166
Mallinckrodt Enterprises LLC	2	$125
Amarin Pharma, Inc.	7	$111
Otsuka Pharmaceutical Development & Commercialization, Inc.	4	$104
Daiichi Sankyo Inc.	5	$100
ANI Pharmaceuticals, Inc.	4	$93
Takeda Pharmaceuticals U.S.A., Inc.	5	$90
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$84
OPKO Pharmaceuticals, LLC	5	$80
Boehringer Ingelheim	3	$57
Ultragenyx Pharmaceutical Inc.	2	$46
Cormedix Inc.	1	$36
AbbVie(2 entities)	2	$35
Inspire Medical Systems, Inc.	1	$34
Novo Nordisk	2	$33
Pfizer	2	$33
Sanofi-aventis U.S. LLC	2	$31
Inari Medical, Inc.	1	$30
Genentech USA, Inc.	1	$26
Apellis Pharmaceuticals, Inc.	1	$24
Astellas Pharma US Inc	1	$21
E.r. Squibb & Sons, L.L.C.	1	$15
Cumberland Pharmaceuticals, Inc.	1	$14
Johnson & Johnson	1	$13
Teva Pharmaceuticals USA, Inc.	1	$11

How this compares

$8,489 in reported general payments places this provider in the 80th percentile of 298 nephrology providers in Virginia.

See all nephrology providers in Virginia →

Medicare billing

Part B allowed, 2024

$190,080

Medicare patients

508

Services billed

1,786

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Norfolk

Kiranjit DhillonNorfolk$4.5M
Thomas McCuneNorfolk$386K
Yury KalmanovichNorfolk$309K
Sandeep MagoonNorfolk$204K
Ramin TolouianNorfolk$146K
Abdul ChaudhryNorfolk$32K
Olayiwola AyodejiHampton$7M
Gaurav GuptaRichmond$2.1M
Csaba KovesdySalem$1.5M
Ramon MendezWoodbridge$1.5M

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →